Amid US investment push, Lilly eyes Houston as potential home for $5.9B API plant
Eli Lilly is jockeying for a tax break in Texas as it weighs whether to build a $5.9 billion API facility in Houston, according to a state filing. When reached for comment, Lilly did not go into details about the Texas proposal but confirmed it’s related to the broader $27 billion U.S. manufacturing investment the company unveiled in late February.
Eli Lilly is jockeying for a tax break in Texas as it weighs whether to build a $5.9 billion API facility in Houston, according to a state filing. When reached for comment, Lilly did not go into details about the Texas proposal but confirmed it’s related to the broader $27 billion U.S. manufacturing investment the company unveiled in late February.
